查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726389

美國持續陽壓呼吸器(CPAP) 設備市場：市場規模、佔有率、趨勢分析（按連接方式和最終用途）、細分市場預測（2025-2030 年）

U.S. Continuous Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Connectivity (Connected, Non-connected), By End-use (Home Care Settings, Hospitals & Clinics), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國持續正壓呼吸器市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國持續性陽壓呼吸器（CPAP）設備市場預計到2030年將達到8.2085億美元，2025年至2030年期間的複合年成長率為4.44%。

市場受到多種因素的推動，例如睡眠呼吸中止症和呼吸系統疾病的盛行率不斷上升、CPAP 設備技術的進步、對睡眠呼吸中止症的認知和診斷不斷提高以及支持性報銷政策。

技術進步是美國CPAP 市場的另一個關鍵驅動力。持續的技術創新使得設備更加易於使用、更安靜、更緊湊，從而提高了患者的舒適度和依從性。遠端監控和連接等創新技術的引入使患者能夠追蹤他們的睡眠模式和治療進度，鼓勵他們積極參與醫療保健。

由於醫療和政府機構加強了宣傳宣傳活動，越來越多的人尋求睡眠呼吸中止症的診斷和治療。此外，保險公司優惠的報銷政策使得更多人可以接受 CPAP 治療。認知到 CPAP 療法在預防未治療的睡眠呼吸中止症相關併發症的長期益處，醫療保健提供者現在更有可能推薦和開立 CPAP 設備。

美國持續正壓呼吸器市場：概述

  • 根據連接方式，預計 2024 年網路共享將佔據最大的市場佔有率，達到 68.83%，並在預測期內以最快的複合年成長率成長。該領域的成長得益於睡眠呼吸中止症管理的進步，例如即時監測和改進的客製化治療技術整合。
  • 根據最終用途，居家醫療領域預計將在 2024 年佔據最大的市場佔有率，並在預測期內以最快的複合年成長率成長。阻塞型睡眠呼吸中止症(OSA) 的日益流行和 CPAP 技術的進步推動了這個細分市場的擴張，導致居家醫療CPAP 治療越來越受到患者的歡迎，成為一種經濟實惠、舒適且方便的解決方案。
  • 美國CPAP 設備市場的主要企業包括 ResMed、Koninklijke Philips NV、Fisher &Paykel Healthcare Limited 和 Medical Depot, Inc.
  • 2024年11月，Fisher & Paykel Healthcare在美國推出了F&P Nova Micro鼻枕面罩。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 市場機會分析
    • 市場問題分析
  • 美國CPAP 設備市場：分析工具、PESTEL 分析
    • 政治/法律
    • 經濟與社會
    • 科技
    • 環境
  • 美國CPAP設備市場：波特五力分析
  • COVID-19影響分析

第4章美國CPAP設備市場：按連接方式的估計和趨勢分析

  • 美國CPAP 設備市場：以連結方式進行銷售分析
  • 美國CPAP 設備市場（按儀錶板和連接方式）
  • 按連接方式分類的市場趨勢和市場佔有率分析（2024 年和 2030 年）
  • 按連線方式
  • 可連接
    • 藍牙連接CPAP
    • Wi-Fi/蜂窩 CPAP
    • 混合連接
  • 未連接

第5章美國CPAP 設備市場：按最終用途進行的估算和趨勢分析

  • 美國CPAP 設備市場：以最終用途分類的銷售分析
  • 美國CPAP 設備市場（按儀表板和最終用途分類）
  • 按最終用途分類的市場趨勢和市場佔有率分析（2024 年和 2030 年）
  • 按最終用途
  • 居家醫療
  • 醫院和診所
  • 其他（護理設施等）

第6章 競爭態勢

  • 公司分類
  • 主要企業進入、退出策略及對競爭對手的影響
  • 企業市場分析
  • 公司佔有率分析（%，2012-2024）
  • 公司簡介/上市公司
    • ResMed
    • Koninklijke Philips NV
    • Fisher &Paykel Healthcare Limited
    • React Health（3B Medical）
    • Lowenstein Medical
    • BMC Medical
    • Wellell（Apex Medical）
    • Armstrong Medical
    • Breas Medical
    • SEFAM
    • Smiths Group PLC
    • Transcend Inc.（Somnetics International, Inc.）
    • Trudell Medical（Vyaire）
    • Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
    • Invacare Corporation
    • 其他
Product Code: GVR-4-68040-556-8

U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends:

The U.S. continuous positive airway pressure devices market is anticipated to reach USD 820.85 million by 2030, registering a CAGR of 4.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.

Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.

Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.

U.S. Continuous Positive Airway Pressure Devices Market Report Highlights:

  • On the basis of connectivity, the connected segment held the largest market share of 68.83% in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The growth of this segment is driven by advancements in sleep apnea management, including improved technology integration for real-time monitoring and tailored care, which enhances user adherence and treatment effectiveness.
  • On the basis of end use, the home care settings segment held the largest market share in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The expansion of this segment is driven by the increasing prevalence of obstructive sleep apnea (OSA) and advancements in CPAP technology, which are increasing the adoption of homecare CPAP therapy as an affordable, comfortable, and convenient solution for patients.
  • Some prominent players in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
  • In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro nasal pillow mask in the U.S., marking the company's smallest and lightest CPAP therapy mask so far.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. CPAP Devices Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Connectivity segment outlook
      • 2.1.2.2. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recalls & failure
      • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Growing adoption of CPAP devices in home care settings
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Regulatory and reimbursement challenges
  • 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
    • 3.4.1. Political & Legal
    • 3.4.2. Economic & Social
    • 3.4.3. Technology
    • 3.4.4. Environment
  • 3.5. U.S. CPAP Market Analysis Tools: Porter's
  • 3.6. COVID 19 Impact Analysis

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

  • 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
  • 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
  • 4.3. Connectivity Movement & Market Share Analysis, 2024 & 2030
  • 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
  • 4.5. Connected
    • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.2. Bluetooth-Connected CPAP
      • 4.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.3. Wi-Fi & Cellular Connected CPAP
      • 4.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
    • 4.5.4. Hybrid-Connected
      • 4.5.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.6. Non-Connected
    • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
  • 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
  • 5.3. End Use Movement & Market Share Analysis, 2024 & 2030
  • 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
  • 5.5. Home Care Settings
    • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 5.6. Hospitals & Clinics
    • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 5.7. Others (Long-Term Care Facilities, etc.)
    • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategies of Market Players for Entry and Exit and its Impact on Market Competitors
  • 6.3. Company Market Position Analysis
  • 6.4. Company Share Analysis, from 2012 to 2024 (%)
  • 6.5. Company Profiles/Listing
    • 6.5.1. ResMed
      • 6.5.1.1. Overview
      • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Koninklijke Philips N.V.
      • 6.5.2.1. Overview
      • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Fisher & Paykel Healthcare Limited
      • 6.5.3.1. Overview
      • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. React Health (3B Medical)
      • 6.5.4.1. Overview
      • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Lowenstein Medical
      • 6.5.5.1. Overview
      • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. BMC Medical
      • 6.5.6.1. Overview
      • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Wellell (Apex Medical)
      • 6.5.7.1. Overview
      • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Armstrong Medical
      • 6.5.8.1. Overview
      • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Breas Medical
      • 6.5.9.1. Overview
      • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. SEFAM
      • 6.5.10.1. Overview
      • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Smiths Group PLC
      • 6.5.11.1. Overview
      • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Transcend Inc. (Somnetics International, Inc.)
      • 6.5.12.1. Overview
      • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Trudell Medical (Vyaire)
      • 6.5.13.1. Overview
      • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
      • 6.5.14.1. Overview
      • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Invacare Corporation
      • 6.5.15.1. Overview
      • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Others
      • 6.5.16.1. Overview
      • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2018 - 2030 (USD Million) (000' Units)
  • Table 4 U.S continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million) (000' Units)

List of Figures

  • Fig. 1 U.S CPAP Devices Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for Market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Technology segment outlook
  • Fig. 11 Application segment outlook
  • Fig. 12 End Use segment outlook
  • Fig. 13 Competitive landscape
  • Fig. 14 U.S CPAP Devices Market: Market dynamics
  • Fig. 15 U.S CPAP Devices Market: Porter's analysis
  • Fig. 16 U.S CPAP Devices Market: PESTLE analysis
  • Fig. 17 U.S CPAP Devices Market: Connectivity segment dashboard
  • Fig. 18 U.S CPAP Devices Market: Connectivity movement share analysis
  • Fig. 19 Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 20 Bluetooth-Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 22 Hybrid-Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 23 Non-Connected Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 24 U.S CPAP Devices Market: End Use Segment Dashboard
  • Fig. 25 U.S CPAP Market: End Use Movement Share Analysis
  • Fig. 26 Home Care Settings Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 27 Hospitals & Clinics Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 28 Others (Long-Term Care Facilities, etc.) Market, 2018 - 2030 (USD Million) (000' Units)
  • Fig. 29 Company categorization
  • Fig. 30 Company Market Share Analysis (2012 - 2024) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
  • Fig. 31 Strategic framework